About
EVQLV develops a proprietary computational platform that uses machine learning and computational biology to accelerate the discovery and design of fully-human antibodies for drug development.
Explore EVQLV's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.